Pelthos TherapeuticsPTHS
13F holders, Q2 2026 (June 30)24holders +7
10new positions
3sold out
1famous investor
$28.26avg. 13F price*
At the end of Q2 2026, 24 institutions reported holding Pelthos Therapeutics Inc. (PTHS) in their 13F filings, up 7 from Q1 2026. 10 opened new positions and 3 sold out. The largest holders were AIGH Capital Management LLC ($9.3M), Murchinson Ltd. ($8.6M) and Ikarian Capital, LLC ($7.3M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Pelthos Therapeutics Inc.
- CUSIP
- 171126204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $11.1M |
| Exits | 3 | $40K |
All 13F filers, Q1 2026 → Q2 2026: 429,059 shares bought and 18,207 shares sold, net +410,852 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| AIGH Capital Management LLC | 0.84% | New | 329,098 | $9.3M |
| Murchinson Ltd. | 4.23% | Add +2.7% | 304,302 | $8.6M |
| Ikarian Capital, LLC | 1.19% | No change | 256,598 | $7.3M |
| Boothbay Fund Management, LLC | 0.06% | Add +24.6% | 101,976 | $2.9M |
| Vanguard Capital Management LLC | 0.00% | Add +4.3% | 97,134 | $2.7M |
| Cantor Fitzgerald, L. P. | 0.02% | Reduce -8.0% | 38,123 | $1.1M |
| J. Goldman & Co LP | 0.04% | Reduce -24.5% | 38,075 | $1.1M |
| Diadema Partners LP | 0.26% | No change | 24,773 | $700K |
| Wexford Capital LP | 0.09% | New | 22,364 | $632K |
| Knott David M Jr | 0.33% | Add +4.8% | 22,073 | $624K |
| Citadel Advisors | 0.00% | New | 15,046 | $425K |
| Geode Capital Management, LLC | 0.00% | Reduce -4.2% | 14,650 | $414K |
| Pale Fire Capital SE | 0.03% | No change | 12,919 | $365K |
| 1492 Capital Management LLC | 0.09% | New | 10,380 | $293K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +0.6% | 9,873 | $279K |
| State Street Corp. | 0.00% | New | 9,800 | $277K |
| Persistent Asset Partners Ltd | 0.05% | No change | 6,007 | $170K |
| BlackRock, Inc. | 0.00% | New | 5,324 | $150K |
| UBS Group AG | 0.00% | Add +190.2% | 2,217 | $63K |
| China Universal Asset Management Co., Ltd. | 0.00% | New | 2,160 | $61K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 205 | $6K |
| Farther Finance Advisors, LLC | 0.00% | No change | 40 | $1K |
| Barclays PLC | 0.00% | New | 20 | $565 |
| Royal Bank of Canada | 0.00% | New | 6 | $0 |
"% of holder's portfolio" is PTHS's weight in each manager's 13F, not the share of Pelthos Therapeutics Inc. the manager owns.